|
US7445924B2
(en)
*
|
2000-11-23 |
2008-11-04 |
Bavarian Nordic A/S |
Modified Vaccinia Ankara virus variant and cultivation method
|
|
US7145057B2
(en)
|
2002-02-01 |
2006-12-05 |
Origen Therapeutics, Inc. |
Chimeric bird from embryonic stem cells
|
|
US20060191026A1
(en)
|
2005-02-18 |
2006-08-24 |
Origen Therapeutics, Inc. |
Tissue specific expression of antibodies in chickens
|
|
FR2836924B1
(fr)
|
2002-03-08 |
2005-01-14 |
Vivalis |
Lignees de cellules aviaires utiles pour la production de substances d'interet
|
|
ES2305514T5
(es)
|
2002-09-05 |
2019-06-14 |
Bavarian Nordic As |
Método para la amplificación de un poxvirus en condiciones exentas de suero
|
|
WO2004056977A1
(en)
*
|
2002-12-13 |
2004-07-08 |
Aventis Pasteur, Inc. |
Production of alvac on avian embryonic stem cells
|
|
EP1500699A1
(en)
*
|
2003-07-22 |
2005-01-26 |
Vivalis |
Production of vaccinia virus with adherent or non adherent avian cell lines
|
|
DK1646715T3
(da)
|
2003-07-22 |
2010-08-16 |
Vivalis |
Fremstilling af poxvirum med adhærente eller ikke-adhærente fuglecellelinjer
|
|
WO2005028634A2
(en)
*
|
2003-09-18 |
2005-03-31 |
Emory University |
Improved mva vaccines
|
|
EP2848692B1
(en)
|
2004-05-21 |
2017-08-16 |
Novartis Vaccines and Diagnostics, Inc. |
Alphavirus vectors for influenza virus vaccines
|
|
ATE489965T1
(de)
|
2004-09-09 |
2010-12-15 |
Novartis Vaccines & Diagnostic |
Verminderung von potentiellen iatrogenen risiken in verbindung mit influenza impfstoffen
|
|
US20090004222A1
(en)
*
|
2004-11-03 |
2009-01-01 |
O'hagan Derek |
Influenza Vaccination
|
|
FR2878860A1
(fr)
*
|
2004-12-08 |
2006-06-09 |
Vivalis Sa |
Lignees de cellules souches humaines derivees de cellules es et utilisations pour la production de vaccins et de proteines recombinantes
|
|
AU2011253998B2
(en)
*
|
2005-04-11 |
2014-04-24 |
Valneva |
Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
|
|
FR2884255B1
(fr)
*
|
2005-04-11 |
2010-11-05 |
Vivalis |
Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
|
|
ES2525518T3
(es)
|
2005-11-01 |
2014-12-26 |
Novartis Vaccines And Diagnostics Gmbh |
Vacunas virales derivadas de células con niveles reducidos de ADN celular residual
|
|
NZ594482A
(en)
|
2005-11-04 |
2012-11-30 |
Novartis Vaccines & Diagnostic |
Influenza vaccines with reduced amount of oil-in-water emulsion as adjuvant
|
|
JP2009514844A
(ja)
|
2005-11-04 |
2009-04-09 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
スプリットインフルエンザワクチン用のアジュバントとしての遊離水相界面活性剤を含むエマルション
|
|
NZ568211A
(en)
|
2005-11-04 |
2011-11-25 |
Novartis Vaccines & Diagnostic |
Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
|
|
CN102755645A
(zh)
|
2005-11-04 |
2012-10-31 |
诺华疫苗和诊断有限公司 |
佐剂配制的包含细胞因子诱导剂的流感疫苗
|
|
CA2628152C
(en)
|
2005-11-04 |
2016-02-02 |
Novartis Vaccines And Diagnostics S.R.L. |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
|
PL2478916T3
(pl)
|
2006-01-27 |
2020-11-16 |
Seqirus UK Limited |
Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy
|
|
FR2898909A1
(fr)
|
2006-03-24 |
2007-09-28 |
Agronomique Inst Nat Rech |
Combinaison de marqueurs de cellules aviaires
|
|
CN101448523A
(zh)
|
2006-03-24 |
2009-06-03 |
诺华疫苗和诊断有限两合公司 |
无需冷藏储存流感疫苗
|
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
|
MX2009001477A
(es)
|
2006-08-09 |
2009-02-18 |
Vivalis |
Metodo de produccion de un aviar transgenico utilizando celulas progenitoras embrionicas.
|
|
EP4585610A3
(en)
|
2006-09-11 |
2025-09-24 |
Seqirus UK Limited |
Making influenza virus vaccines without using eggs
|
|
PT2121011E
(pt)
|
2006-12-06 |
2014-07-31 |
Novartis Ag |
Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
|
|
CN100443588C
(zh)
*
|
2006-12-11 |
2008-12-17 |
中国农业科学院北京畜牧兽医研究所 |
静宁鸡胚成纤维细胞系及其培养方法
|
|
EP1985305A1
(en)
*
|
2007-04-24 |
2008-10-29 |
Vivalis |
Duck embryonic derived stem cell lines for the production of viral vaccines
|
|
EP1995309A1
(en)
*
|
2007-05-21 |
2008-11-26 |
Vivalis |
Recombinant protein production in avian EBx® cells
|
|
KR20100045437A
(ko)
|
2007-06-27 |
2010-05-03 |
노파르티스 아게 |
첨가물이 적은 인플루엔자 백신
|
|
JP5421250B2
(ja)
*
|
2007-07-03 |
2014-02-19 |
トランスジーン ソシエテ アノニム |
トリ不死化細胞株
|
|
US20090028831A1
(en)
*
|
2007-07-23 |
2009-01-29 |
University Of Kentucky Research Foundation |
Stem cell regulator, compositions and methods of use
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
AU2008339631B2
(en)
|
2007-12-24 |
2014-07-24 |
Novartis Ag |
Assays for adsorbed influenza vaccines
|
|
US8506966B2
(en)
|
2008-02-22 |
2013-08-13 |
Novartis Ag |
Adjuvanted influenza vaccines for pediatric use
|
|
JP5653223B2
(ja)
*
|
2008-02-25 |
2015-01-14 |
バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated |
連続細胞系の生成方法
|
|
JP5518041B2
(ja)
|
2008-03-18 |
2014-06-11 |
ノバルティス アーゲー |
インフルエンザウイルスワクチン抗原の調製における改良
|
|
WO2009132195A1
(en)
*
|
2008-04-23 |
2009-10-29 |
Michigan State University |
Immortal avian cell line and methods of use
|
|
ES2539045T3
(es)
|
2009-01-19 |
2015-06-25 |
Innate Pharma |
Anticuerpos anti-KIR3D
|
|
EP3173097A3
(en)
|
2009-02-10 |
2017-07-12 |
Seqirus UK Limited |
Influenza vaccines with reduced amounts of squalene
|
|
CA2752041A1
(en)
|
2009-02-10 |
2010-08-19 |
Novartis Ag |
Influenza vaccines with increased amounts of h3 antigen
|
|
EA201171032A1
(ru)
|
2009-02-10 |
2012-02-28 |
Новартис Аг |
Схемы лечения с помощью вакцины против гриппа, связанного с пандемическими штаммами
|
|
USH2283H1
(en)
|
2009-04-27 |
2013-09-03 |
Novartis Ag |
Vaccines for protecting against influenza
|
|
CA2768186A1
(en)
|
2009-07-15 |
2011-01-20 |
Novartis Ag |
Rsv f protein compositions and methods for making same
|
|
US20120237536A1
(en)
|
2009-09-10 |
2012-09-20 |
Novartis |
Combination vaccines against respiratory tract diseases
|
|
GB0918830D0
(en)
|
2009-10-27 |
2009-12-09 |
Glaxosmithkline Biolog Niederl |
Process
|
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
|
CA2725435C
(en)
|
2009-12-15 |
2023-01-03 |
University Of Saskatchewan |
Vaccines for inclusion body hepatitis
|
|
EP2531592A1
(en)
|
2010-02-04 |
2012-12-12 |
Vivalis |
Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
|
|
FR2956409A1
(fr)
|
2010-02-15 |
2011-08-19 |
Univ Claude Bernard Lyon |
Procedes pour optimiser la production virale par l'inactivation ou l'inhibition du gene hipk2 et cellules modifiees pour la production virale
|
|
US9494571B2
(en)
|
2010-03-08 |
2016-11-15 |
Novartis Ag |
Methods of testing for intracellular pathogens
|
|
EP2374816B1
(en)
|
2010-04-07 |
2016-09-28 |
Agency For Science, Technology And Research |
Binding molecules against Chikungunya virus and uses thereof
|
|
WO2011124635A1
(en)
|
2010-04-07 |
2011-10-13 |
Humalys |
Binding molecules against chikungunya virus and uses thereof
|
|
US9744228B2
(en)
|
2010-04-07 |
2017-08-29 |
Norvartis Ag |
Method for generating a parvovirus B19 virus-like particle
|
|
US9426989B2
(en)
|
2010-05-06 |
2016-08-30 |
Novartis Ag |
Organic peroxide compounds for microorganism inactivation
|
|
CN103025350A
(zh)
|
2010-05-21 |
2013-04-03 |
诺华有限公司 |
流感病毒的重配方法
|
|
CA2801151A1
(en)
|
2010-06-01 |
2011-12-08 |
Novartis Ag |
Concentration of vaccine antigens with lyophilization
|
|
WO2011151723A2
(en)
|
2010-06-01 |
2011-12-08 |
Novartis Ag |
Concentration of vaccine antigens without lyophilization
|
|
AU2011276328C1
(en)
|
2010-07-06 |
2016-01-21 |
Novartis Ag |
Norovirus derived immunogenic compositions and methods
|
|
GB201011502D0
(en)
|
2010-07-08 |
2010-08-25 |
Glaxosmithkline Biolog Sa |
Novel process
|
|
WO2012023044A1
(en)
|
2010-08-20 |
2012-02-23 |
Novartis Ag |
Soluble needle arrays for delivery of influenza vaccines
|
|
JP6283223B2
(ja)
|
2010-09-07 |
2018-02-21 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
多能性幹細胞を培養するための新規な方法および培養培地
|
|
FR2967072B1
(fr)
|
2010-11-05 |
2013-03-29 |
Univ Dundee |
Procede pour ameliorer la production de virus et semences vaccinales influenza
|
|
WO2012095514A1
(en)
|
2011-01-14 |
2012-07-19 |
Vivalis |
Recombinant protein production system
|
|
WO2012103361A1
(en)
|
2011-01-26 |
2012-08-02 |
Novartis Ag |
Rsv immunization regimen
|
|
CA2835644C
(en)
|
2011-05-13 |
2021-06-15 |
Novartis Ag |
Pre-fusion rsv f antigens
|
|
EP2729165B1
(en)
|
2011-07-06 |
2017-11-08 |
GlaxoSmithKline Biologicals SA |
Immunogenic combination compositions and uses thereof
|
|
CA2841047A1
(en)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Immunogenic compositions and uses thereof
|
|
TWI623618B
(zh)
|
2011-07-12 |
2018-05-11 |
傳斯堅公司 |
Hbv聚合酶突變體
|
|
TW201318637A
(zh)
|
2011-09-29 |
2013-05-16 |
Transgene Sa |
免疫療法組成物及用於治療c型肝炎病毒感染之療程(一)
|
|
WO2013045668A2
(en)
|
2011-09-29 |
2013-04-04 |
Transgene Sa |
Immunotherapy composition and regimen for treating hepatitis c virus infection
|
|
US20140348863A1
(en)
|
2011-10-12 |
2014-11-27 |
Alessia Bianchi |
Cmv antigens and uses thereof
|
|
GB201216121D0
(en)
|
2012-09-10 |
2012-10-24 |
Novartis Ag |
Sample quantification by disc centrifugation
|
|
EP2768528A1
(en)
|
2011-10-20 |
2014-08-27 |
Novartis AG |
Adjuvanted influenza b virus vaccines for pediatric priming
|
|
EP2660316A1
(en)
|
2012-05-02 |
2013-11-06 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Avian cell line and its use in production of protein
|
|
US20150140068A1
(en)
|
2012-07-06 |
2015-05-21 |
Novartis Ag |
Immunogenic compositions and uses thereof
|
|
TWI638829B
(zh)
|
2012-07-10 |
2018-10-21 |
法商傳斯堅公司 |
分枝桿菌抗原疫苗
|
|
WO2014009433A1
(en)
|
2012-07-10 |
2014-01-16 |
Transgene Sa |
Mycobacterium resuscitation promoting factor for use as adjuvant
|
|
GB201218195D0
(en)
|
2012-10-10 |
2012-11-21 |
Istituto Zooprofilattico Sperimentale Delle Venezie |
Composition
|
|
EP2922570A1
(en)
|
2012-11-20 |
2015-09-30 |
GlaxoSmithKline Biologicals SA |
Rsv f prefusion trimers
|
|
US20140255447A1
(en)
*
|
2013-03-05 |
2014-09-11 |
Biomune Company |
Production of avian embryo cells
|
|
FR3008992A1
(fr)
*
|
2013-07-25 |
2015-01-30 |
Agronomique Inst Nat Rech |
Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires
|
|
WO2015104380A1
(en)
|
2014-01-09 |
2015-07-16 |
Transgene Sa |
Fusion of heterooligomeric mycobacterial antigens
|
|
EP2974739A1
(en)
|
2014-07-15 |
2016-01-20 |
Novartis AG |
RSVF trimerization domains
|
|
EP3031822A1
(en)
|
2014-12-08 |
2016-06-15 |
Novartis AG |
Cytomegalovirus antigens
|
|
US11147887B2
(en)
|
2014-12-17 |
2021-10-19 |
Fundación Para La Investigación Mèdica Aplicada |
Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson disease
|
|
US11118238B2
(en)
|
2014-12-17 |
2021-09-14 |
Fundación Para La Investigación Mèdica Aplicada |
Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson's disease and other conditions
|
|
EP3047856A1
(en)
|
2015-01-23 |
2016-07-27 |
Novartis AG |
Cmv antigens and uses thereof
|
|
US11013795B2
(en)
|
2015-06-26 |
2021-05-25 |
Seqirus UK Limited |
Antigenically matched influenza vaccines
|
|
KR102790570B1
(ko)
|
2015-07-07 |
2025-04-04 |
세퀴러스 유케이 리미티드 |
인플루엔자 효능 검정
|
|
KR20260047644A
(ko)
|
2017-03-30 |
2026-04-08 |
더 유니버서티 어브 퀸슬랜드 |
키메라 분자 및 그의 용도
|
|
EP3687561A4
(en)
|
2017-09-01 |
2021-06-09 |
The Australian National University |
"immunoregulatory molecules and uses therefor"
|
|
EP3717505A4
(en)
|
2017-12-01 |
2021-12-01 |
Encoded Therapeutics, Inc. |
GENENICALLY MODIFIED DNA-BINDING PROTEINS
|
|
WO2019219649A1
(en)
|
2018-05-14 |
2019-11-21 |
Vivet Therapeutics |
Gene therapy vectors comprising s/mar sequences
|
|
MX2020012895A
(es)
|
2018-05-30 |
2021-05-27 |
Inst Res Biomedicine |
Modificacion de linfocitos b al utilizar citidina desaminasa inducida por activacion endogena.
|
|
EP3820884B1
(en)
|
2018-07-13 |
2025-09-03 |
Valneva SE |
Method for rescuing and producing a virus in avian cells
|
|
US20210292791A1
(en)
|
2018-10-12 |
2021-09-23 |
Vivet Therapeutics |
Codon-optimized transgene for the treatment of progressive familiar intrahepatic cholestasis type 3 (pfic3)
|
|
AU2019375450A1
(en)
|
2018-11-07 |
2021-06-17 |
Vivet Therapeutics |
Codon-optimized ABCB11 transgene for the treatment of progressive familial intrahepatic cholestasis type 2 (PFIC2)
|
|
EP3880809A4
(en)
|
2018-11-16 |
2023-01-11 |
Encoded Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF WILSON'S DISEASE
|
|
SG11202104869SA
(en)
|
2018-11-23 |
2021-06-29 |
Valneva Se |
Food products comprising avian stem cells
|
|
WO2020234888A1
(en)
|
2019-05-22 |
2020-11-26 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
|
PL3976798T3
(pl)
|
2019-05-29 |
2026-04-07 |
Encoded Therapeutics, Inc. |
Kompozycje i sposoby selektywnej regulacji genów
|
|
JP7852185B2
(ja)
|
2019-07-02 |
2026-04-28 |
フンダシオン・パラ・ラ・インベスティガシオン・メディカ・アプリカダ |
cPLA2e誘導剤及びその使用
|
|
US20220273789A1
(en)
|
2019-07-21 |
2022-09-01 |
Glaxosmithkline Biologicals Sa |
Therapeutic viral vaccine
|
|
WO2021014385A1
(en)
|
2019-07-24 |
2021-01-28 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|
|
JP2022548179A
(ja)
*
|
2019-09-10 |
2022-11-16 |
バイタル ミート |
食品製造のための鳥類幹細胞
|
|
EP4061930A1
(en)
|
2019-11-18 |
2022-09-28 |
Seqirus Pty Ltd |
Method for producing reassortant influenza viruses
|
|
CN116390773A
(zh)
|
2020-08-06 |
2023-07-04 |
应用医学研究基金会 |
用于通过基因疗法治疗诸如阿尔茨海默病的Tau蛋白病的病毒颗粒
|
|
US20230265456A1
(en)
|
2020-08-10 |
2023-08-24 |
Fundacion Para La Investigacion Medica Aplicada |
Gene therapy vector expressing cyp27a1 for the treatment of cerebrotendinous xanthomatosis
|
|
IL301255A
(en)
|
2020-10-09 |
2023-05-01 |
UCB Biopharma SRL |
Nucleic acid structures, viral vectors and viral particles
|
|
WO2022136616A1
(en)
|
2020-12-23 |
2022-06-30 |
Vivet Therapeutics |
Minimal bile acid inducible promoters for gene therapy
|
|
EP4032547A1
(en)
|
2021-01-20 |
2022-07-27 |
GlaxoSmithKline Biologicals S.A. |
Hsv1 fce derived fragements for the treatment of hsv
|
|
EP4423286A1
(en)
|
2021-10-28 |
2024-09-04 |
UCB Biopharma SRL |
Nucleic acid constructs, viral vectors and viral particles
|
|
WO2023144665A1
(en)
|
2022-01-28 |
2023-08-03 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|
|
CN114480286B
(zh)
*
|
2022-02-16 |
2024-05-31 |
上海健士拜生物科技有限公司 |
无血清悬浮型lmh细胞系及其制备方法和应用
|
|
CN116656628A
(zh)
*
|
2023-07-31 |
2023-08-29 |
深圳市卫光生物制品股份有限公司 |
一种痘病毒载体疫苗的制备方法
|
|
EP4567102A1
(en)
|
2023-12-05 |
2025-06-11 |
Suprême |
Methods for isolating embryonic stem cells from avian embryonic cells
|
|
CN118956737A
(zh)
*
|
2024-07-17 |
2024-11-15 |
广州沃亘生物科技有限公司 |
一种长期维持df-1细胞活力的培养基及其用途
|